There is fresh hope for millions of people who suffer with migraines on a regular basis as a top research team in the UK believe they may have developed a drug that can relieve pain and cut the duration of an attack.
The revolutionary new drug called Erenumab, which was developed at the Kings College Hospital London is said to have cured the pain over over 500 trial patients in half the time that it takes for traditional medicines to reduce symptoms.
It is believed the new drug which is a lab-made antibody works by blocing a neural brain pathway called CGRP.
The drug which is still being tested was used as part of recent medical trial which involved over 1,000 patients. Following the extensive trial results showed a success rate of over 50% as many of those who took part revealed the drug alleviated their symptoms in a shorter time frame than normal .
Although the drug is yet to go into mass production researchers say they are hopeful that it will be introduced in the near future as the latest trials have shown that the drug can be beneficial to those who suffer with the crippling illness.
It is thought that on average over half a million people in Ireland suffer from migraines on a regular basis with many experiencing symptoms such as ap throbbing headache, nausea, fatigue and vomiting.